Dr. Mitchell B. Weisberg, MD

Dr. Weisberg practices at Laboratory Corporation of America in Zephyrhills, Florida.

Dr. Weisberg's NPI, 1336120906, was assigned on November 9, 2005. Dr. Weisberg graduated from American University of the Caribbean School of Medicine in 1988. Dr. Weisberg holds Florida license ME63365.

Dr. Weisberg's primary practice is Laboratory Corporation of America, at 5611 St, Zephyrhills, FL 33542 in Pasco County. The practice phone is (800) 877-5227.

Dr. Weisberg's primary practice is Laboratory Corporation of America in Zephyrhills, Florida. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Weisberg to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weisberg practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Weisberg's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Weisberg is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Weisberg's licenses on file in 3 states: Florida, Georgia and Alabama.

Dmand AI lists chronic anemia, chronic leukemia, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Weisberg treats.

CMS data shows 36 Medicare services from Dr. Weisberg across 2 procedure codes in 2023, all of them office visits, for 14 Medicare patients. Medicare paid $2,775 for them. Every service was in an office.

CMS counts 14 Medicare patients who saw Dr. Weisberg in 2024. The largest group is under 65, with 0 patients. 75% of them have high cholesterol. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weisberg's median patient age at 77, with 54% women.

In 2024, Dr. Weisberg wrote 291 Medicare Part D claims for 59 patients. 77% of them were for generic drugs. CMS names the drug for 196 of them, across 10 drugs with 11 or more claims each, at $450,062 in total drug cost. In 2023, CMS named 307 claims across 10 drugs.

Dr. Weisberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 317 general payments to Dr. Weisberg from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,021.

Dr. Weisberg graduated from American University of the Caribbean School of Medicine in 1988.

Dr. Weisberg is in network with 7 carriers, including Elevance, Excellus BlueCross BlueShield and Humana. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.